A Mother’s Recollection of a UCSF Medical Center Cancer Ward and its Compassionate Nurses
source: pixabay.com

A Mother’s Recollection of a UCSF Medical Center Cancer Ward and its Compassionate Nurses

Steven Rodriguez was nineteen years old attending college in California when he began to have severe headaches. A recent article from the UCSF Science Center gives an account of Steven’s…

Continue Reading A Mother’s Recollection of a UCSF Medical Center Cancer Ward and its Compassionate Nurses
Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?
source: pixabay.com

Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?

According to a story from yahoo.finance.com, the medical technology company iCAD, Inc. recently held a webinar featuring several brain tumor experts that discussed the potential of an approach called intraoperative…

Continue Reading Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?
A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
source: pixabay.com

A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer

  Toxoplasmosis is transmitted by Toxoplasma gondii, the protozoan parasite which is known to be among the most common parasites worldwide. The infection occurs from contaminated meat, cat feces that…

Continue Reading A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
FDA Grants Rare Pediatric Disease Designation for WP1066
GDJ / Pixabay

FDA Grants Rare Pediatric Disease Designation for WP1066

The FDA has recently granted its Rare Pediatric Disease designation to Moleculin's WP1066 for three indications: atypical teratoid rhabdoid tumor, diffuse intrinsic pontine glioma, and medulloblastoma. This designation will aid…

Continue Reading FDA Grants Rare Pediatric Disease Designation for WP1066
An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals, Inc. has announced recently that its experimental diagnostic 64Cu-SARTATE™ has earned Rare Pediatric Disease designation from the US Food…

Continue Reading An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation